• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Investig Med High Impact Case Rep . Diabetes Insipidus and Concomitant Myocarditis: A Late Sequelae of COVID-19 Infection

tetano

Editor, Senior Moderator
J Investig Med High Impact Case Rep


. Jan-Dec 2021;9:2324709621999954.
doi: 10.1177/2324709621999954.
Diabetes Insipidus and Concomitant Myocarditis: A Late Sequelae of COVID-19 Infection


Abu Baker Sheikh[SUP] 1 [/SUP], Nismat Javed[SUP] 2 [/SUP], Abdul Ahad Ehsan Sheikh[SUP] 3 [/SUP], Shubhra Upadhyay[SUP] 1 [/SUP], Rahul Shekhar[SUP] 4 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019 (COVID-19), which has become a global pandemic. Apart from the mild features of the disease, long-term complications involve many systems including both endocrine and cardiovascular systems. Myocarditis, secondary to COVID-19, has become a well-known complication of the disease. However, endocrine complications are generally not common, particularly isolated pituitary abnormalities. There is one other report of diabetes insipidus developing as a late sequela of COVID-19. In this article, we report a case of a young male who presented with features of myocarditis but developed diabetes insipidus on day 7 of admission as a long-term complication after recovery from COVID-19 infection. His laboratory test results at the time of developing the complication revealed a high serum sodium level and low urine osmolality. The patient recovered on administration of desmopressin and was discharged after 16 days of hospitalization.

Keywords: COVID-19; complication; diabetes insipidus; myocarditis.
 
Back
Top Bottom